Calcium antagonists and renal hemodynamics: implications for renal protection
- PMID: 1794210
Calcium antagonists and renal hemodynamics: implications for renal protection
Abstract
Recently, attention has focussed on the effects of calcium antagonists on renal function. When administered in vitro to the isolated perfused kidney, calcium antagonists exhibit consistent actions permitting characterization of their renal hemodynamic effects. Calcium antagonists do not affect the vascular tone of the vasodilated isolated perfused kidney, but they do dramatically reverse the response of this preparation to vasoconstrictor agents. Studies using the isolated hydronephrotic rat kidney model, which permits direct visualization of afferent and efferent arterioles, have demonstrated that calcium antagonists selectively vasodilate preglomerular vessels. The clinical implications of such observations are still being delineated. Nevertheless, the results of preliminary studies in experimental animal models and in human transplant recipients suggest that calcium antagonists exert salutary effects on renal function in clinical settings characterized by impaired renal hemodynamics. Furthermore, a case can be made that these salutary renal hemodynamic effects of calcium antagonists commend their use in the management of essential hypertension.
Similar articles
-
Effects of calcium antagonists on renal hemodynamics.Am J Kidney Dis. 1990 Oct;16(4 Suppl 1):10-4. Am J Kidney Dis. 1990. PMID: 2220795 Review.
-
Calcium antagonists and the kidney: implications for renal protection.J Cardiovasc Pharmacol. 1991;18 Suppl 10:S64-70. J Cardiovasc Pharmacol. 1991. PMID: 1725007 Review.
-
Calcium antagonists and the kidney: implications for renal protection.Kidney Int Suppl. 1992 May;36:S66-72. Kidney Int Suppl. 1992. PMID: 1614071 Review.
-
Calcium antagonists and the kidney.J Cardiovasc Pharmacol. 1994;24 Suppl A:S18-24. J Cardiovasc Pharmacol. 1994. PMID: 7603073 Review.
-
Diltiazem and renal hemodynamics: implications for renal protection.J Cardiovasc Pharmacol. 1991;18 Suppl 9:S21-5. J Cardiovasc Pharmacol. 1991. PMID: 1725538 Review.
Cited by
-
T-type Ca2+ channels and autoregulation of local blood flow.Channels (Austin). 2017 May 4;11(3):183-195. doi: 10.1080/19336950.2016.1273997. Epub 2017 Jan 5. Channels (Austin). 2017. PMID: 28055302 Free PMC article. Review.